Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals (AERI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 538,167
  • Shares Outstanding, K 46,514
  • Annual Sales, $ 69,890 K
  • Annual Income, $ -199,580 K
  • 60-Month Beta 0.82
  • Price/Sales 8.12
  • Price/Cash Flow N/A
  • Price/Book 6.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.81
  • Number of Estimates 6
  • High Estimate -0.72
  • Low Estimate -0.84
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +5.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.22 +14.15%
on 08/28/20
12.33 -5.38%
on 09/09/20
+0.27 (+2.34%)
since 08/21/20
3-Month
10.22 +14.15%
on 08/28/20
16.20 -27.98%
on 06/23/20
-4.21 (-26.53%)
since 06/22/20
52-Week
10.22 +14.15%
on 08/28/20
26.26 -55.57%
on 01/09/20
-11.66 (-49.99%)
since 09/20/19

Most Recent Stories

More News
Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rhopressa(R) (netarsudil ophthalmic solution) 0.02%

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 11.53 (-0.35%)
Glaucoma Therapeutics Market to Reach USD 11.05 Billion at 6.1% CAGR by 2027; Rising Research on Prostaglandin Analogs, says Fortune Business Insights(TM)

The global glaucoma therapeutics market is set to gain impetus from the increasing research activities on prostaglandin analogs. It is further creating a surging shift of patients towards this drug class....

AERI : 11.53 (-0.35%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
NVS : 88.76 (-0.83%)
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 11.53 (-0.35%)
Glaucoma Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is estimated to value over USD 10.1 billion by 2027 end with a CAGR of over 6% during the forecast period 2020 to 2027.

AERI : 11.53 (-0.35%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
NVS : 88.76 (-0.83%)
PFE : 35.91 (-0.31%)
SNPHF : 20.1000 (+5.79%)
TEVA : 8.90 (-0.56%)
VRX.TO : 30.80 (-3.33%)
New Strong Sell Stocks for August 10th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

CBT : 36.61 (+2.38%)
BHLB : 9.36 (-1.89%)
AERI : 11.53 (-0.35%)
ETM : 1.4000 (+0.71%)
FTDR : 42.02 (-1.04%)
4.3% Return Seen to Date on SmarTrend Aerie Pharmaceut Call (AERI)

SmarTrend identified a Downtrend for Aerie Pharmaceut (NASDAQ:AERI) on July 9th, 2020 at $13.05. In approximately 4 weeks, Aerie Pharmaceut has returned 4.29% as of today's recent price of $12.49.

AERI : 11.53 (-0.35%)
Aerie (AERI) Q2 Earnings Miss Estimates, Revenues Rise Y/Y

Aerie (AERI) posts a wider-than-expected loss and sales miss estimates in the second quarter of 2020.

EBS : 98.71 (-1.29%)
ALIM : 5.36 (-3.25%)
AERI : 11.53 (-0.35%)
ACIU : 8.93 (+0.45%)
Aerie: 2Q Earnings Snapshot

NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Thursday reported a loss of $48.2 million in its second quarter.

AERI : 11.53 (-0.35%)
Aerie Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

--Positive Phase 2 Topline Results for AR-1105 Implant Indicate up to Six-Month Sustained Release

AERI : 11.53 (-0.35%)
Aerie Pharmaceuticals Appoints Peter J. McDonnell, M.D., to the Company's Board of Directors

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 11.53 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AERI with:

Business Summary

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are...

See More

Key Turning Points

2nd Resistance Point 12.34
1st Resistance Point 11.95
Last Price 11.53
1st Support Level 11.24
2nd Support Level 10.92

See More

52-Week High 26.26
Fibonacci 61.8% 20.13
Fibonacci 50% 18.24
Fibonacci 38.2% 16.35
Last Price 11.53
52-Week Low 10.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar